Expression of cyclin D1 and its association with disease characteristics in bladder cancer

Pradeep Kumar Kopparapu, Stephen A. Boorjian, Brian D. Robinson, Martin Downes, Lorraine J. Gudas, Nigel P. Mongan, Jenny L. Persson

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Aim: Invasive urothelial carcinoma of the bladder (UCB) is characterized by alterations in cell-cycle regulatory pathways. Defects in the expression of cyclin D1, a key cellcycle regulator, have been implicated in progression of various types of cancer. In the present study, we investigated whether cyclin D1 expression is associated with clinicopathological parameters and whether it has any potential prognostic value in determining risk of UCB recurrence. Patients and Methods: Tissue microarrays containing bladder cancer specimens (n=212) and adjacent normal bladder tissues (n=131) were immunostained using an antibody against cyclin D1. The association between cyclin D1 and clinicopathological parameters including stage, lymph node metastasis, and disease-free survival, were evaluated. Cyclin D1 mRNA expression data from human normal bladder (n=14) and cancer specimens (n=28) were extracted from the public Oncomine database. Results: Cyclin D1 mRNA and protein expression were significantly higher in UCB compared to adjacent nonmalignant bladder tissue (for mRNA p=0.003, for protein p=0.001). Cyclin D1 protein expression was significantly higher in non-invasive tumors than in muscle-invasive UCB (p=0.016). Among patients with muscle-invasive UCB, increased cyclin D1 expression in tumor cells significantly correlated with lymph node metastasis (p<0.001), and there was a trend of cyclin D1 together with lymph node positivity to be associated with disease recurrence (p=0.678). Loss of nuclear cyclin D1 expression in tumor cells was likewise significantly associated with the presence of lymph node metastasis (p<0.001). Conclusion: Altered expression of cyclin D1 is associated with lymph node metastasis and risk of UCB recurrence. Cyclin D1 expression may therefore have clinical value as a prognostic marker and potential therapeutic target.

Original languageEnglish (US)
Pages (from-to)5235-5242
Number of pages8
JournalAnticancer research
Issue number12
StatePublished - Dec 2013


  • Biomarker
  • Bladder cancer
  • Cyclin D1
  • Muscle-invasive

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Expression of cyclin D1 and its association with disease characteristics in bladder cancer'. Together they form a unique fingerprint.

Cite this